Cargando…

Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores

There is the potential for high-dimensional information about patients collected in clinical trials (such as genomic, imaging, and data from wearable technologies) to be informative for the efficacy of a new treatment in situations where only a subset of patients benefits from the treatment. The ada...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherlin, Svetlana, Wason, James M.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611900/
https://www.ncbi.nlm.nih.gov/pubmed/32662542
http://dx.doi.org/10.1002/sim.8665